Sigrid Therapeutics
PrivateLast Round
VC Round
Jan 7, 2026
Est. Valuation
$65.88M
Total Funding Raised
$8.4M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Sigrid Therapeutics is a biotechnology company that develops non-pharmaceutical therapies for metabolic diseases using its proprietary SiPore® technology.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Clinical Trials
Business Model
B2C
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Sigrid Therapeutics Comparables
Compare Sigrid Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Gelesis Holdings Inc. | 76% | |
| AltrixBio Inc. | 76% | |
| Allurion | 67% | |
Sigrid Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Jan 7, 2026 | ||||
| VC Round | Oct 31, 2023 | ||||
| VC Round | Jan 16, 2023 | ||||
| Series A | Nov 10, 2021 | ||||
| VC Round | Sep 5, 2019 | ||||
Grant | May 28, 2019 |
Key People
Founding team and executive leadership
Sigrid Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Axilium Capital | VC Round |
| Almi Invest AB | Grant |
| Joyance Partners | Series A, VC Round |
| Irrus Investments | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 15, 2026
Grew 68% QoQ, from 19 to 32 employees.
- May 17, 2026
Grew 53% QoQ, from 17 to 26 employees.
Sigrid Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Sigrid Therapeutics's valuation, stock price, and market status.